A previous study demonstrated that gene expression of MFG-E8 was significantly increased in tumor tissues from patients with cholangiocarcinoma and suggested that MFG-E8 is a promising biomarker for the management of cholangiocarcinoma [18]. The gene discussed is MFGE8; the disease is cholangiocarcinoma.